Relationship between p53 overexpression, human papillomavirus infection, and lifestyle in Indian patients with head and neck cancers

Tumor Biology

Volumn 33, Issue 2, 2012, Pages 543-550

  Jamaly, Simin ^a   Khanehkenari, Mehrdad Rakaee ^a   Rao, Raghavendra ^c   Patil, Geeta ^b   Thakur, Suresh ^d,f   Ramaswamy, Poongothai ^d   Ajaikumar, B S ^c   Sahoo, Rashmita ^b,e  

^a Brindavan College   (India)

^b Triesta Sciences   (India)

^c HCG Enterprises Ltd   (India)

^d BioGenex Life Science Pvt Ltd   (India)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

^f TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Head and neck cancer; HPV; Indian patients; Lifestyle; P53; Prognostic markers

Indexed keywords

PROTEIN P53; TP53 PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CHI SQUARE TEST; CIGARETTE SMOKING; CORRELATION COEFFICIENT; DIETARY INTAKE; DNA PROBE; FEMALE; GENOTYPE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIFESTYLE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGED; BIOSYNTHESIS; COHORT ANALYSIS; COMORBIDITY; ETHNOLOGY; GENE EXPRESSION REGULATION; HEAD AND NECK TUMOR; HELA CELL; INDIA; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; PREVALENCE; PROGNOSIS; REGRESSION ANALYSIS; TUMOR SUPPRESSOR GENE; VIROLOGY;

AGED; COHORT STUDIES; COMORBIDITY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENES, P53; HEAD AND NECK NEOPLASMS; HELA CELLS; HUMANS; INDIA; LIFE STYLE; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROGNOSIS; REGRESSION ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84860310885     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0295-x     Document Type: Article

References (36)

1. Ferreira MB, De Souza JA, Cohen EE. Role of molecular markers in the management of head and neck cancers. Curr Opin Oncol. 2011;23(3):259-64.
2. Syrjänen S. Human papillomaviruses in head and neck carcinomas. N Engl J Med. 2007;356(19):1993-5.
3. Lane DP. P53 Guardian of the Genome. Nature (Lond). 1992;358:15-6.
4. Notani PN. Global variation in cancer incidence and mortality. Curr Sci. 2001;81:465-74.
5. Lindeberg H, Krogdahl A. Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas. Cancer Lett. 1999;146:9-13.
6. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2005. CA Cancer J Clin. 2005;55:74-108.
7. Gupta PC, Nandakumar A. Oral cancer scene in India. Oral Dis. 1999;5:1-2.
8. Syrjanen S. Human papillomaviruses in head and neck carcinomas. N Engl J Med. 2007;356:1993-5.
9. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467-75.
10. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ, Fuchs PG. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer. 2001;92:2875-84.
11. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-56.
12. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813-20.
13. Reimers N, Kasper HU, Weissenborn SJ, Stutzer H, Preuss SF, Hoffmann TK, Speel EJ, Dienes HP, Pfister HJ, Guntinas-Lichius O, Klussmann JP. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120:1731-8.
14. Hafkamp HC, Manni JJ, Haesevoets A, Voogd AC, Schepers M, Bot FJ, Hopman AH, Ramaekers FC, Speel EJ. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer. 2008;122:2656-64.
15. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-9.
16. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck. 1998;20(3):250-65.
17. Goon PKC, Stanley MA, Ebmeyer J, et al. HPV & head and neck cancer:a descriptive update. Head Neck Oncol. 2009;1:36.
18. Paterson IC, Eveson JW, Prime SS. Molecular change in oral cancer may reflect aetiology and ethnic origin. Eur J Cancer B Oral Oncol. 1996;32B:150-3.
19. Hecht SS. Tobacco carcinogens, their biomarkers and tobaccoinduced cancer. Nat Rev Cancer. 2003;3:733-44.
20. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA, Sidransky D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332:712-7.
21. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52:195-215.
22. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9-22.
23. Poschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol. 2004;39:155-65.
24. Barchaman DG, Graves D, Vokes E, et al. Occurrence of p53gene deletion and human papilloma virus infection in human head and neck cancer. Cancer Res. 1992;52:4832-6.
25. Haraf DJ, Nodzenski E, Brachman D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res. 1996;2:755-62.
26. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100(6):407-20. Epub 2008 Mar 11.
27. Maier H, Zöller J, Herrmann A, Kreiss M, Heller WD. Dental status and oral hygiene in patients with head and neck cancer. Otolaryngol Head Neck Surg. 1993;108(6):655-61.
28. Bishop JM.Molecular themes in oncogenesis. Cell. 1991;64:235-48.
29. Bensaad K, Vousden KH. p53: new roles in metabolism. Trends Cell Biol. 2007;17:286-91.
30. D'Souza G, Kreimer AR, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-56.
31. de Oliveira DE, Bacchi MM, Ricardo SS, et al. Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol. 2006;126:284-93.
32. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol. 2006;24 (17):2606-11.
33. Brown DR, Kjaer SK. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis. 2009;199(7):926-35.
34. Münger K. The role of human papillomaviruses in human cancers. Front Biosci. 2002;7:d641-9.
35. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550-60. Epub 2010 Jul 1.
36. Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev. 2004;68(2):362-72.